AKT1 and colorectal carcinoma: Notably, we identified the underlying mechanism: 5‐FU not only downregulates the expression of MARCH1, but also inhibits the expression of the PI3K/AKT pathway to repress the proliferation, migration, and invasion of CRC in vitro.